Dialysis Equipment

CytoSorbents, Inc. is a medical technology company specializing in hemoadsorption blood purification therapy. The company develops extracorporeal adsorption devices based on proprietary biocompatible polymer bead technology designed to reduce elevated levels of potentially harmful compounds from whole blood. The primary product, CytoSorb 300®, is an adsorber that complements conventional dialysis approaches and is used in critical care, cardiovascular, liver, and kidney therapeutic areas. CytoSorbents also offers PuriFi, an independent therapy platform enabling standalone CytoSorb® use; ECOS-300CY for ex vivo organ perfusion applications; and VetResQ for veterinary critical-care applications. The company maintains a global presence in over 75 countries and provides clinical support through a team of specialists. Products are CE-marked and available internationally, though CytoSorb 300® and related human therapeutics are not authorized or cleared in the US market. VetResQ is available only in the US. The company positions itself as a trusted partner for advanced blood purification technologies in settings where physiological balance and management of inflammatory or harmful substances is critical.

Byonyks Medical Devices is a medical device manufacturer focused on next-generation peritoneal dialysis systems for home-based kidney failure treatment. The company has received FDA 510(k) clearance for its X-1 Automated Peritoneal Dialysis (APD) Cycler, positioning it among a select group of manufacturers offering FDA-cleared APD devices. Byonyks' technology platform addresses a significant clinical need: the U.S. government's initiative to transition 80% of dialysis patients to home-based or transplant therapies, representing a major paradigm shift in a $120 billion industry that has relied on 40-year-old technology. The company's next-generation peritoneal dialysis systems are engineered to preserve peritoneal membrane integrity through biocompatible, toxin-free dialysate formulations, thereby extending patients' tenure on peritoneal dialysis therapy. Key product benefits include slower decline in residual kidney function (supported by the BALANZ clinical study), elimination of acid and pro-inflammatory mediators from dialysate, reduced malnutrition and atherosclerosis risk, and lower treatment costs through cost-effective consumables and high-performance device design. Byonyks serves the home dialysis market in the United States and internationally, targeting patients with chronic kidney disease seeking improved quality of life and clinical outcomes through home-based treatment modalities.

Phraxis is a medical device company specializing in innovative endovascular solutions for hemodialysis access. The company's flagship product, EndoForce™ Connector, is an FDA-approved device designed to create arteriovenous grafts (AVG) for hemodialysis patients using a minimally invasive, endovascular approach. EndoForce™ eliminates the need for surgical dissection required in traditional sutured anastomosis techniques and enables precise, coaxial vessel-to-graft alignment through standard transcatheter methods. The device features a patented design incorporating a flexible nitinol segment for versatile implantation angles and a rigid segment with nitinol barbs for secure attachment. In pivotal clinical trials, EndoForce™ demonstrated a 92% cumulative patency rate, exceeding the 80% rate associated with conventional suture anastomosis, thereby extending graft longevity and reducing complications. The company was founded by Dr. Alex Yevzlin, an interventional nephrologist whose clinical expertise in dialysis access informed the product's development. Phraxis targets nephrology and vascular surgery markets, addressing critical clinical challenges in hemodialysis access creation with a precision-engineered, reproducible endovascular solution.

Quanta Dialysis Technologies manufactures the Quanta Dialysis System, an award-winning hemodialysis platform designed to deliver kidney replacement therapy across multiple care settings—acute care (ICU), post-acute facilities (LTAC, skilled nursing/rehabilitation), in-center chronic dialysis, and home-based self-care. The system is FDA-cleared (510(k) K222067 and K242269) to support multiple modalities—Intermittent Hemodialysis (IHD), Sustained Low-Efficiency Dialysis (SLED), Continuous Renal Replacement Therapy (CRRT), and Prolonged Intermittent Renal Replacement Therapy (PIRRT)—from a single platform without the need for dialysate bags or daily rinses. Key clinical features include a wide blood flow range (Qd 50–500 mL/min), precision electrolyte control (sodium and potassium), and an intuitive touchscreen interface enabling rapid staff training (4.5–6 hours). The system weighs 71 lbs and features a compact, modular design suitable for resource-constrained or transitional care environments. Maintenance requires only once-weekly hot rinses, with no harsh chemical disinfections. The company received the prestigious Royal Academy of Engineering MacRobert Award in 2022 for on-demand dialysate technology. Home hemodialysis clearance (2024) permits patient use with a trained care partner, with >95% success rate in human factors testing and 84% patient retention post-trial. Blood tube sets are single-use, disposable accessories. Quanta serves hospitals, dialysis centers, long-term acute care facilities, skilled nursing facilities, rehabilitation centers, and home dialysis patients across North America and Europe.

Unilene, SAC is a Peruvian medical device manufacturer and distributor specializing in surgical consumables and healthcare solutions for over 25 years. The company manufactures and distributes advanced sutures, plastics, wound care products, sterilization equipment and supplies, oxygen therapy devices, critical care products, and hemodialysis accessories. Unilene serves hospitals, pharmacies, public health institutions, and distributors throughout Latin America, with particular strength in Peru and Ecuador. The company operates manufacturing facilities and provides ethylene oxide sterilization services for medical devices. Unilene holds multiple international certifications including ISO 9001:2015 (quality management), ISO 13485:2016 (medical device quality systems), ISO 45001:2018 (occupational health and safety), IQNet certification, BPM (Good Manufacturing Practices), and BPA (Good Storage Practices). FDA clearance confirms compliance with U.S. safety and efficacy standards. The company functions as an original equipment manufacturer (OEM) for third-party brands and operates its own product lines across surgical, wound care, sterilization, oxygen therapy, critical care, and hemodialysis categories.

Transit Scientific, LLC manufactures minimally invasive vascular intervention devices focused on peripheral vasculature and dialysis access applications. The company's primary product platform is the XO Score® Sheath Platform, an FDA 510(k) and CE Mark cleared device designed for use with percutaneous transluminal angioplasty (PTA) balloons to facilitate dilation and vessel wall apposition in treating stenotic lesions across multiple vascular territories. Indicated applications include iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, as well as obstructive lesions in native or synthetic arteriovenous dialysis fistulae. The company also offers the XO Cross® Catheter Platform, similarly FDA 510(k) and CE Mark cleared, designed to guide and support guidewires during peripheral vascular access, enable wire exchanges, and serve as a delivery conduit for saline solutions or diagnostic contrast agents. The XO Cath microcatheter line extends the portfolio for controlled and selective infusion of diagnostic, embolic, or therapeutic materials into peripheral vessels, with demonstrated clinical use in transradial embolic delivery procedures. All products are cleared for peripheral vascular intervention but explicitly contraindicated for coronary and neuro-vascular applications. Transit Scientific positions itself within the interventional cardiology and peripheral vascular device sector, targeting interventionalists and vascular surgeons managing stenotic disease and dialysis access complications.

DIASOL, INC. is a manufacturer and distributor of hemodialysis concentrates, dialysis equipment, and related consumables. The company operates two manufacturing facilities in Phoenix, Arizona and Watertown, Tennessee, with three distribution warehouses serving southern California, northern California, and Texas. DIASOL manufactures customized hemodialysis concentrates in multiple formulations, offering variable electrolyte compositions including potassium (0–4K), calcium (0–3, 5 CA), and magnesium (0.75–1.0–1.5 MG) concentrations, as well as dextrose options (100 and 200 mg/dl). The company supplies dialysis chairs, bloodlines, accessories, and ancillary consumables such as alcohol prep pads and adhesive bandages. DIASOL holds ISO certification (as of 2020) and focuses on rapid fulfillment and efficient distribution through strategically positioned logistics infrastructure. The company serves dialysis centers and nephrology practices requiring customizable dialysate formulations to meet individual patient prescriptions.

CloudCath is a digital health medical device company that develops remote monitoring solutions for peritoneal dialysis (PD) patients. The company's flagship product, CloudCath Connect™ PD, is an add-on device for PD cyclers that utilizes optical analysis, IoT sensors, machine learning, and cloud computing to measure turbidity in dialysate effluent. By quantifying fluid analysis rather than relying on subjective visual assessment, CloudCath enables early detection of peritonitis and other complications—on average 3.1 days before patient-reported symptoms. Clinical evidence demonstrates a 45% reduction in peritonitis-related hospitalization and 56% reduction in catheter loss. The system seamlessly integrates with major PD cyclers (Baxter and Fresenius), provides real-time notifications to patients and clinicians, and supports continuous home-based monitoring to shift care from in-center facilities. This innovative approach enhances patient outcomes, improves therapy adherence, and reduces the need for emergency interventions in end-stage renal disease management.

Henan Tuoren Medical Device Co., Ltd. is a Chinese healthcare solutions provider specializing in medical consumables, electronic medical devices, surgical instruments, and biomedical materials. The company operates over 50 subsidiaries and manufactures more than 220 product types across 1,880 specifications. Primary therapeutic areas include anesthesia, pain management, nursing care, diagnostic testing, general surgery, hemodialysis, and interventional procedures. Tuoren positions itself as a distributor and manufacturer of safe, user-friendly medical devices with emphasis on innovative value-added solutions, competitive pricing, and customer service. The company has established international presence, participating in major medical conferences including the American Society of Anesthesiologists Annual Meeting and EUROANAESTHESIA. Products span consumable supplies through advanced electronic medical devices, indicating a broad portfolio approach to hospital and clinical procurement. The company's strategy includes merger and acquisition activities and joint ventures to expand product diversification.

C.R. Bard (now part of BD) is a diversified global medical technology company operating through multiple business segments: BD Interventional, BD Life Sciences, and BD Medical. The company manufactures and distributes an extensive portfolio of medical devices, consumables, and diagnostic solutions across vascular access, medication delivery, infection prevention, laboratory diagnostics, surgical instruments, and specialty medical equipment. Through the Medivance acquisition (2011), Bard offers the Arctic Sun™ Targeted Temperature Management system for precise patient temperature control in critical care settings. The company serves hospitals, healthcare systems, clinical laboratories, and other healthcare facilities with products spanning syringes and needles, catheters (central and peripheral), infusion systems, surgical mesh and grafts, diagnostic culture media, molecular testing systems, blood collection products, stents, and specialty equipment for urology, cardiology, gynecology, and interventional medicine. With thousands of SKUs across therapeutic areas including vascular surgery, gastrointestinal care, wound management, and microbiology solutions, Bard functions as a comprehensive B2B medical device and consumables supplier.

Sonavex develops automated 3D ultrasound solutions for dialysis access care, enabling quantification and visualization of critical clinical data. The company specializes in vascular assessment and cannulation guidance for arteriovenous fistula management. Primary product lines include EchoSure, which automatically measures volumetric flow rate, diameter, and depth of blood vessels; EchoMark, a patented ultrasound marker designed specifically for blood vessel visualization and tracking; and EchoMap, an intuitive vessel mapping system supporting cannulation procedures. These solutions are designed for point-of-care use across multiple clinical settings. The company is led by a multidisciplinary team including physicians, scientists, and technologists focused on delivering clinical and economic value to patients and health systems. Sonavex's technology addresses critical gaps in dialysis vascular access management, where accurate vessel assessment and maturation monitoring are essential for patient outcomes. The company has gained recognition in medical technology media and maintains a physician-supported, patient-oriented development approach.

Nuwellis, Inc. is a commercial-stage medical device manufacturer specializing in ultrafiltration therapy systems for fluid management in cardiorenal patients. Founded in 1999 and headquartered in Eden Prairie, Minnesota, the company develops and markets the Aquadex FlexFlow System and Aquadex SmartFlow System—precision ultrafiltration devices designed to remove excess fluid in patients with heart failure, acute kidney injury, chronic kidney disease, and cardiorenal syndrome when diuretics prove inadequate. The systems deliver predictable, isotonic fluid removal while protecting organ function and reducing hospitalizations and readmissions. Nuwellis supports critical care, pediatric, nephrology, cardiology, and outpatient settings with comprehensive clinical evidence from 65+ peer-reviewed studies spanning 20+ years. The company provides integrated cardiorenal management solutions, clinical training, reimbursement support, and dedicated customer service to healthcare providers globally, addressing both acute perioperative fluid management and chronic disease management.

Patients Care Medical Supply is a locally owned durable medical equipment (DME) provider based in Maurice, Louisiana, serving Lafayette and surrounding Acadiana communities. The company supplies a comprehensive range of home health essentials and mobility aids, including hospital beds, power wheelchairs, respiratory therapy products, CPAP equipment, diabetic supplies, wound care materials, patient lifts, and incontinence products. They also offer bracing and support devices, bathroom safety equipment, and lymphedema management solutions. Patients Care Medical Supply accepts Medicare, Medicaid, major insurance plans, FSA/HSA, credit cards, and CareCredit, positioning itself as a patient-centered supplier committed to serving caregivers and patients in the home healthcare market.

AMPARO Medical Technologies is a manufacturer and formulator of medical-grade hydrocolloid adhesives headquartered in Anaheim, California. The company specializes in custom-formulated hydrocolloid products for medical device attachment, wound care, ostomy, catheter securement, negative pressure wound therapy (NPWT), and cosmetic applications including acne patches. All manufacturing is conducted in-house at the Anaheim facility using raw materials sourced from the USA and Europe. The company's hydrocolloid formulations are engineered to provide superior adhesion to moist skin, high absorbency, and non-skin-sensitizing performance—characteristics that have made hydrocolloid the gold standard in wound care and ostomy for over 50 years. Products can be customized with active ingredients for pain relief, drug delivery, and therapeutic applications. AMPARO's Quality Management System is ISO 13485:2016 accredited by BSI, and all formulations are compliant with ISO 10993 biocompatibility standards, EU REACH and RoHS regulations, and California Proposition 65. The company offers master roll manufacturing with configurable performance characteristics (adhesion, absorption, modulus), physical dimensions (width, thickness, single or double-sided), and component selections (polyurethane or polyethylene film carriers; polyester or paper release liners). Services include design development, technical consultation, and 100% product verification testing conducted by the company's in-house testing laboratory.

Arjo is a global medical technology company headquartered in Malmö, Sweden, founded in 1957. With approximately 6,500 employees and presence in over 100 countries, Arjo specializes in patient handling, mobility, hygiene, and pressure injury prevention solutions. The company's core product portfolio includes safe patient handling equipment (including the Maxi Move® 5 floor lifter system and SARA technology), comprehensive medical bed ranges, hygiene solutions (including the innovative Symbliss® bathing system), pressure injury prevention surfaces and clinical seating, disinfection systems, and venous thromboembolism (VTE) prevention equipment with pumps and compression garments. Arjo serves hospitals, health systems, acute care facilities, and long-term care settings. The company emphasizes evidence-based care through its Arjo MOVE programs and Positiva Åttan philosophy, which promote mobility outcomes, staff safety, operational efficiency, and patient dignity. Arjo also offers reprocessing solutions (ReNu technology) and equipment rental options to support healthcare sustainability and cost management.

Diener Precision Pumps (DPP) is a custom gear pump and metering pump manufacturer serving medical, laboratory, diagnostic, and industrial markets. The company designs and manufactures precision pumps engineered in the USA with production in Switzerland (Embrach). Core product lines include gear pumps (Silencer, Optima, Extreme, Multistream series) for high-volume fluid transfer and continuous flow applications; metering/dosing pumps (Precision and Dual-Precision series) for micro-dosing in diagnostic and analytical equipment; and variable dispense pumps (Exacta series) for sensitive medical applications. DPP specializes in custom OEM solutions with minimum order volume of 100 units/year. Medical and laboratory applications include hemodialysis and peritoneal dialysis systems, laboratory and clinical diagnostics equipment, disinfection and sterilization systems for surgical instruments, and medical device fluid handling. All pumps are manufactured to tight tolerances, tested 100% pre-shipment, laser-marked for traceability, and feature advanced drive electronics for responsive flow and pressure control. The company operates an R&D facility in Lodi, California with prototype capabilities delivering samples within 2–15 days, and maintains quality certifications including NSF/ANSI 169 certification for food-service applications.

CSL Behring LLC is a global biotechnology company specializing in plasma-derived and recombinant biotherapies for rare and serious diseases. The company manufactures and distributes immunoglobulins, clotting factor concentrates for hemophilia and bleeding disorders, therapies for immunodeficiencies, treatments for hereditary angioedema, and Alpha-1 antitrypsin deficiency products. As part of the larger CSL Limited group (founded 1916), CSL Behring operates manufacturing and distribution networks across over 100 countries, with significant recent investment ($1.5 billion) in U.S. plasma-based medicine manufacturing. The company emphasizes quality management, regulatory compliance, and innovation in cell culture reagents and plasma collection infrastructure. CSL's broader portfolio includes CSL Seqirus (vaccines, including influenza and pandemic preparedness), CSL Vifor (iron deficiency and nephrology/dialysis therapies), and CSL Plasma (plasma source plasma collection). With over 25,000 employees globally, the organization focuses on delivering life-saving therapies for bleeding disorders, immune system conditions, and chronic kidney disease.

DEKA Research & Development Corporation is a Manchester, New Hampshire-based medical device and advanced technology company founded in 1982 by Dean Kamen. With over 1,000 engineers and technicians and more than 6,000 patents, DEKA specializes in the research, design, development, and manufacturing of innovative healthcare solutions. The company's medical device portfolio includes infusion systems, subcutaneous drug delivery platforms, portable dialysis innovations, and organ preservation technologies. DEKA also develops therapeutic self-administration devices and regenerative manufacturing technologies. Beyond healthcare, the company creates mobility enhancement solutions (including the iBOT wheelchair), autonomous robotics, and water purification systems. DEKA operates a partnership-driven business model, licensing technologies to major corporations including Johnson & Johnson and Baxter Healthcare to accelerate market adoption. The company generates approximately $105.7 million in annual revenue and is deeply committed to STEM education through its sponsorship of FIRST Robotics.

Global Healthcare is an international medical supplier established in 1993, headquartered in Alpharetta, Georgia, with operational presence in Colombia and the USA. The company specializes in manufacturing and distributing a comprehensive portfolio of disposable medical products, durable medical equipment, and healthcare supplies. Their core product lines include respiratory care equipment, wound care products (dressings, gauze, bandages), clinical care supplies, suction equipment, surgical clothing, medical furniture (clinical beds, wheelchairs and mobility aids), and dialysis equipment. With over 170 SKUs in their healthcare catalog, GHC supports healthcare facilities and professionals through efficient distribution, stringent quality control, and compliance with international standards. The company maintains commitment to innovation and process optimization, positioning itself as a competitive B2B supplier for multi-country healthcare networks.

CRO Medical™ is a service-disabled veteran-owned manufacturer headquartered in Missoula, Montana, dedicated to enhancing prehospital and austere medicine. The company designs and manufactures field-tested medical equipment and carriers for military, law enforcement, EMS, and civilian emergency responders. CRO develops innovative point-of-injury (POI) care solutions including damage control resuscitation (DCR) kits, specialized medical bags, pelvic binders, airway management devices, blood transport containers, and modular medical kit systems. The company accelerates the transfer of medical technology from research and development to commercialization through a user-generated platform, leveraging feedback from end-users in tactical, combat, and austere environments. Products are purpose-built for rapid deployment, harsh conditions, and prolonged casualty care scenarios.

Nipro Corporation is a global healthcare company headquartered in Osaka, Japan, with over 70 years of experience serving patients, healthcare professionals, and pharmaceutical companies. The company operates three primary business segments: medical devices, pharmaceuticals, and pharmaceutical packaging. Nipro's medical division is a global market leader in renal care, providing comprehensive dialysis solutions including water treatment systems, dialysis machines, and related disposables. The company also manufactures high-quality disposable medical equipment for hospitals and home care, including needles, syringes, IV sets, and infusion pumps. Nipro's diabetes care portfolio features glucose monitoring systems such as the 4SURE Smart meters. In home infusion therapy, Nipro offers the Surefuser™+ elastomeric infusion pump for ambulatory chemotherapy and drug delivery. The vascular division provides intravascular imaging systems and interventional cardiology tools. Additionally, Nipro manufactures pharmaceutical packaging solutions, including pre-fillable glass syringes and pharmaceutical containers. The company also operates iMEP (Institute for Medical Practice), providing training and education to healthcare professionals globally, and offers infection control solutions including the CLFine environmental disinfection system.

Molded Products is an FDA-registered medical device manufacturer specializing in injection molded dialysis products and supplies since 1986. The company manufactures over 200 dialysis-specific products including transducer protectors, dialyzer holders, fistula clamps, and related components. In addition to dialysis equipment, Molded Products serves veterinary, laboratory, and apheresis industries. The firm offers end-to-end contract manufacturing services including custom mold design, precision machining, and custom packaging. Materials expertise spans plastics and metals. While the company also serves non-medical sectors (semiconductor, agricultural, commercial refrigeration), its core B2B business focuses on supplying FDA-compliant medical devices and components to healthcare providers and equipment manufacturers.

Fresenius Medical Care is the world's leading provider of dialysis products, services, and therapies for individuals with renal diseases. The company operates approximately 3,600 dialysis centers worldwide and serves around 292,000 patients, delivering over 44 million dialysis treatments annually. With ~110,000 employees and 35 production sites globally, Fresenius manufactures and supplies a comprehensive range of renal therapy solutions including dialysis machines, consumables, vascular access products, and related medical devices and pharmaceuticals for end-stage renal disease (ESRD) management. The company serves healthcare professionals and patients through clinic-based in-center hemodialysis, peritoneal dialysis, and home-based therapies. Fresenius holds regulatory approvals including FDA clearance and CE marking for its medical devices, with compliance to medical device regulations (MDR), ISO 13485, and REACH/SVHC standards. The organization provides training, education, and clinical support services to healthcare professionals and maintains a robust quality and regulatory affairs infrastructure globally.

Summit International Medical Technologies is a specialty medical device manufacturer focused on critical care, anesthesia, dialysis, and neonatal markets. The company develops, manufactures, and distributes clinically innovative disposable and durable medical products designed to enhance patient safety and clinician efficiency while providing cost-effective care solutions. Key product lines include: Covalon AquaGuard moisture barrier systems for IV sites, PICC lines, and wound dressings; Parasol Medical fall prevention systems (wired and wireless) and DrySmart incontinence management pads; Starboard Medical temperature management probes for patient monitoring; Summit Medical AngelTip Safety Fistula for dialysis access; SternaSafe Uni sternum support braces for post-sternotomy recovery and SternaBra for women; Parasol Medical Cultivate quality assurance products for aseptic procedures; and NDI disposable marking spheres for surgical navigation and tracking. The company also acquired the Critical Concepts Inc. neonatal distribution product line in 2020, expanding its NICU offerings. Summit operates primarily in the United States, serving hospitals, critical care units, dialysis centers, and surgical facilities. The company emphasizes clinician-trusted, easy-to-use solutions with measurable clinical outcomes such as reduced complications, faster patient recovery, and improved safety. Products are designed for both acute hospital settings and post-operative care environments.

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. Founded in 1987 and headquartered in South Jordan, Utah, the company employs approximately 7,000 people worldwide and serves hospitals and physicians across the globe. Merit specializes in devices for cardiology, radiology, oncology, critical care, and endoscopy applications. The product portfolio includes catheters, guide wires, balloons, inflation devices, syringes, needles, stents, biopsy tools, drainage systems, embolics and delivery systems, access devices, and monitoring equipment. Merit serves multiple clinical specialties including interventional cardiology, interventional radiology, gastroenterology, critical care, electrophysiology, nephrology, pulmonology, breast surgery, and interventional oncology. The company offers procedural solutions for cardiac catheterization, dialysis access, biopsy procedures, embolotherapy, stricture management, spine interventions, and structural heart applications. Merit operates globally with manufacturing and distribution capabilities supporting complex interventional procedures. The company provides clinician education through Merit's Think Education program and maintains regulatory compliance appropriate for disposable medical devices in the United States and international markets.

DynaFlex is a leading FDA-registered orthodontic and dental medical device manufacturer headquartered in Lake Saint Louis, Missouri. Established in 1965, the company has grown to become one of the largest orthodontic laboratories in the United States, with over 150 employees and approximately $16.6 million in annual revenue. DynaFlex operates across five core market segments: custom orthodontic appliance manufacturing, orthodontic product distribution, clear aligner systems, digital office solutions, and dental sleep medicine devices. The company manufactures a comprehensive portfolio including custom orthodontic appliances, the SmileShare™ clear aligner system for teeth alignment, FDA-cleared obstructive sleep apnea devices, and the 3D.Ortho® digital platform for clinical workflow optimization. DynaFlex's product lines include advanced bracket systems (Norris Metal and Clear brackets), MARPE expanders, retention systems (Defend), bonded accessories (CS5, Precision Buttons), and specialized dental sleep medicine devices. The company combines advanced manufacturing technology with high-quality materials and dedicated customer service, positioning itself as a B2B supplier to orthodontic practices, dental laboratories, and sleep medicine clinicians seeking premium appliances and digital solutions.

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. The company specializes in hemodialysis concentrates and related solutions for patients with end-stage kidney disease (ESKD). Rockwell Medical's product portfolio includes hemodialysis concentrates and Triferic (ferric pyrophosphate citrate), an iron replacement therapy. The company serves dialysis centers and renal care providers globally, focusing on reliability, quality, and customer service. Rockwell Medical emphasizes long-term innovation strategies to enhance product efficacy, manufacturing processes, and clinical outcomes for vulnerable patient populations dependent on hemodialysis therapy. The company is recognized for unmatched reliability and comprehensive customer support, with operations including manufacturing, distribution, and technical support for dialysis facilities.

TNT Moborg International Ltd. is a manufacturer of innovative dialysis access securement and control solutions. Since 1995, the company has specialized in the Immobilé family of products, which serve as alternatives to traditional tape for line, catheter, and needle control in both hemodialysis and peritoneal dialysis (PD) settings. The product portfolio includes Immobilé (for PD access control and hemodialysis), Immobilé-AC (for line and catheter control in hemodialysis), Immobilé-FST (for needle access control), Immobilé Tape Kit (a tape dispenser for all hemodialysis modalities), and Immobilé Opti-Flo (for cannulation angle control). These solutions are designed for use in both clinic and home dialysis environments. The company emphasizes patient safety, ease of use, and time-saving benefits for healthcare professionals. All product use is coordinated with trained dialysis nurses to ensure proper application and patient safety. The company's focus is on redefining standards in dialysis care through streamlined, secure, and patient-centric solutions.

AOSS Medical Supply, Inc. is a US-based distributor and manufacturer of medical supplies and consumables specializing in plasma collection, dialysis, and clinical laboratory products. The company operates an FDA-certified kit packing facility and offers customized nursing and medical school kits. Primary product lines include blood collection tubes (BD Vacutainer, BD Microtainer), fistula needles for arteriovenous fistulas (JMS products), dialysis supplies and accessories, plasma collection solutions, laboratory consumables, personal protective equipment (PPE), and wound care products. AOSS serves diverse markets including dialysis centers, plasma collection facilities, clinical laboratories, EMS providers, dental practices, tattoo studios, educational institutions, food and beverage, spa, and janitorial sectors. The company emphasizes bulk order discounts, fast and secure shipping (2–3 day processing, 5–7 day delivery domestically), customer service support, and satisfaction guarantees. Leadership includes CEO Eric Liew and COO/President Linda Liew. AOSS maintains quality focus and offers products meeting FDA approval standards. The company handles physician license verification for restricted products and provides 30-day returns (excluding PPE items). No specific regulatory certifications (510(k), ISO 13485, CE marking) are explicitly stated on the site, though FDA-certified kit packing capability is mentioned.

Outset Medical, Inc. manufactures and distributes the Tablo Hemodialysis System, an integrated medical device designed to simplify acute and home dialysis treatment. The Tablo is a versatile, all-in-one hemodialysis platform engineered to reduce operational complexity, improve clinical outcomes, and lower treatment costs across the care continuum—from intensive care units and acute hospital settings to in-center dialysis programs and home hemodialysis. The system features automated setup and teardown, cloud-based connectivity with two-way wireless data transfer, and seamless electronic medical record (EMR) integration via the Outset Connect analytics platform. Nurses can be trained on Tablo operation in fewer than four hours; the device supports multiple treatment modalities and achieves adequate dialysis clearance at standard treatment frequencies. Clinical evidence demonstrates reduced infection rates, shorter ICU stays, improved patient symptom indices, and enhanced hospital operational efficiency. Outset provides comprehensive support services including clinical training, technical service, and implementation assistance. The company serves nearly 1,000 hospitals and health systems across the United States, targeting acute care hospitals, critical access hospitals, rural health systems, and patients eligible for home hemodialysis. The Tablo holds FDA clearance and is designed for use in acute, ICU, in-center dialysis, home hemodialysis, inpatient rehabilitation, long-term acute care, and skilled nursing facility settings.

Organ Recovery Systems, Inc. is a specialized medical device manufacturer focused on organ preservation and transportation technology for transplantation. The company is best known for developing LifePort Kidney Transporter, the first portable hypothermic machine perfusion (HMP) system introduced in 2003, which has preserved over 275,000 kidneys across more than 22 years of clinical use. ORS also manufactures LifePort Liver Transporter, designed for precision-controlled dual perfusion of hepatic artery and portal vein using hypothermic machine perfusion with redundant preservation systems for safety. The company serves organ procurement organizations (OPOs), transplant centers, and transplant professionals worldwide. Their preservation solutions include specialized physiologic solutions formulated for organ preparation, storage, transportation, and transplantation. LifePort devices are lightweight, portable systems designed to minimize tissue damage through cold perfusion while organs transit from recovery to recipient. Clinical evidence published in peer-reviewed journals, including the New England Journal of Medicine, demonstrates significantly better 1-year and 3-year graft survival rates for deceased donor kidneys preserved with LifePort technology compared to static cold storage. ORS provides comprehensive support services including 24/7 clinical expert helpline staffed by personnel with over 200 combined years in organ preservation experience, on-site and online training modules, wet labs, mobile troubleshooting applications (available in English, Portuguese, French, and Spanish), and equipment servicing. The company maintains regulatory compliance and quality management systems aligned with medical device standards. ORS operates offices in Chicago, Illinois, and Diegem, Belgium, serving transplant programs globally.

Safe N Simple LLC manufactures and distributes high-quality ostomy, wound care, and urological medical supplies for both acute and chronic care settings. The company offers a comprehensive product portfolio including ostomy pouches, skin barriers, hernia belts, conforming seals, adhesive removers, peri-stoma cleansers, wound care dressings, catheters, and urological drainage systems. Products are designed for leak protection, skin health, ease of use, and patient dignity. The company serves patients managing colostomies, ileostomies, urostomies, chronic wounds, diabetic foot ulcers, post-surgical recovery, and short- and long-term urological needs. Safe N Simple operates a B2C e-commerce platform and provides educational resources including a free sample program (Simple Start Kit), patient education content covering ostomy management, diet, travel, and daily living, and a mobile app for ostomy care tracking and support community access. The company also offers private labeling and white-label manufacturing services for healthcare partners. All products emphasize user-friendly design, discretion, and clinical performance suitable for home and clinical use.

Mozarc Medical is a healthcare technology company dedicated to improving kidney health, launched in April 2023 as a spinoff leveraging expertise from Medtronic's former Renal Care Solutions business. The company offers a comprehensive portfolio of kidney health solutions including hemodialysis catheters, peritoneal dialysis catheters, safety fistula cannulas, and specialized pediatric dialysis systems. Mozarc Medical emphasizes reducing complications and enhancing patient access to care, particularly for in-home dialysis environments. The company provides clinical support, education, and training resources to healthcare providers and patients, focusing on holistic kidney care solutions spanning vascular access through treatment delivery. Led by CEO Ven Manda with a global workforce, Mozarc Medical serves nephrology practices, dialysis centers, and home care programs treating chronic kidney disease, end-stage renal disease, and acute kidney injury patients.

BC Group International, Inc. (operating as Lloyd Industries, Inc.) is a comprehensive distributor and manufacturer of biomedical test equipment and measurement instruments for the global medical device technical services marketplace. The company functions as a "one-stop-shop" providing sales of test equipment and tools, calibration services, and repair services for general and biomedical-specific test equipment across multiple brands and types. BC Group manufactures and distributes its proprietary BC Biomedical line of products, which includes Electrical Safety Analyzers, Defibrillator Analyzers, Electrosurgical (ESU) Analyzers, Infusion Device Analyzers, NIBP Simulators, Patient Simulators, Pulse Oximetry (SpO2) Simulators, and Digital Pressure Meters (standard and high-accuracy variants). The product portfolio encompasses testing and measurement equipment for anesthesia and respiratory systems, medical gas analysis, oxygen analyzers, HVAC systems, environmental air quality monitoring, cable and LAN testers, EMF monitors, power line disturbance monitors, ultrasound imaging and wattmeters, radiology equipment, temperature and humidity monitoring, and general-purpose test equipment including multimeters, oscilloscopes, and tachometers. The company operates multiple service divisions: BC Depot (depot calibration and repair), BC Onsite (on-site calibration services), and BC Quality Programs (certified quality assurance). BC Group maintains an online store and offers downloadable product catalogs, manuals, and technical references. The company serves biomedical engineering departments, clinical engineering teams, hospitals, medical device manufacturers, and service organizations. All products are available through their online marketplace, and the company emphasizes compliance with industry standards and regulations for biomedical equipment testing and validation.

Redsense Medical develops and manufactures patented fiber optic blood leak detection systems designed for hemodialysis access monitoring. The company's core offering detects venous needle dislodgement and central catheter leakage through innovative fiber optic sensor technology, triggering immediate alarms to prevent blood loss. The system is available in two configurations: venous fistula and central catheter solutions. Redsense devices are FDA-cleared and CE-marked for use across all dialysis modalities. The alarm unit integrates with IEC PAS 63023-compliant dialysis machines, enabling automatic blood flow stoppage when leakage is detected. The technology addresses a critical patient safety gap in hemodialysis by enabling rapid detection and response to access complications. Redsense operates across Europe and North America with a focus on dialysis provider deployment.

Medical Solutions International is a manufacturer of dialysis equipment and accessories, specializing in recessed patient wall stations and bicarbonate/acid concentrate delivery systems. The company's primary product line is BiPro Mixing Systems, which revolutionized delivery of bicarbonate and acidified concentrates to dialysis stations by eliminating manual jug handling, mixing, and cleaning. BiPro systems provide consistent solution delivery with enhanced quality controls, sanitation, and equipment maintenance. The company also manufactures Wall Tech Stations, wall-mounted distribution systems, acidified concentrate distribution units, drain isolation systems, and related accessories. Products include BiPro Bicarb Mixing and Distribution Systems, BiPro Single Tank Mixer, wall station configurations (including small white wall stations), automatic acid dispensing units, coiled concentrate lines, wand drying systems, and drain hose controls. The systems are designed to reduce staff time loss, prevent spills and mislabeling, and minimize back injuries associated with heavy jug handling in dialysis facilities. Medical Solutions International operates from Kansas and serves acute treatment dialysis centers. The company provides product specification sheets and maintains a product catalog. No FDA, ISO, or other certifications are explicitly mentioned on the website. The business appears to be a specialized niche manufacturer focused exclusively on dialysis facility infrastructure and consumable delivery systems.

Total Quality Medical Inc. is a distributor and supplier of medical-grade products and supplies serving healthcare facilities across the United States for over 20 years. The company specializes in dialysis products, infection control supplies, commercial water filtration systems, and antimicrobial skin and wound care products. Key product lines include the Anasept antimicrobial skin and wound care family, Nephros filters for hospital water filtration, and dialysis-related consumables from partner manufacturers including Nipro and Angelini. TQM also provides water testing services and specialty diagnostic items such as Sterichek test strips. The company positions itself as a cost-effective alternative to larger distributors, offering volume discounts, same-day shipping capabilities, and competitive pricing on specialty dialysis items. Service territory extends from Maine to California. TQM serves hospitals, dialysis centers, and other medical facilities seeking supply chain efficiency and procurement support.

Medica USA Inc. is a vertically integrated biomedical manufacturer and technology developer based in Eden Prairie, Minnesota, with parent company operations in Mirandola, Italy since 1985. The company specializes in blood purification devices and systems, including dialysis, continuous renal replacement therapy (CRRT), and apheresis equipment and disposables. Core competencies span electromedical device design, hollow-fiber membrane technology, and disposable medical device manufacturing. Beyond renal care, Medica serves cardiology, surgical oncology, organ transplantation, urology, and gastroenterology diagnostic markets. The company operates three integrated business units: Medical (blood purification products and devices), Water Purification (industrial and hospital water treatment systems using proprietary membrane technology), and Turnkey Solutions (complete system integration and industrial automation for the biomedical sector). Medica maintains in-house R&D, manufacturing, quality assurance, regulatory affairs, sales, and after-sales service. The company holds an extensive portfolio of proprietary patents and is ISO-certified for medical device production. All products are manufactured under strict compliance with regulatory requirements for US, European, and international markets.

Raivansa Inc., founded in 2003, is a trusted importer and distributor of precision medical instruments and healthcare products serving the United States market. The company specializes in surgical instruments including surgical blades, disposable scalpels, biopsy punches, and dermal curettes, alongside a comprehensive range of medical consumables and disposables. Product offerings span general surgery instruments, medical disposables, personal protective equipment (PPE), wound care supplies, and urology/ostomy products. The company maintains FDA compliance and emphasizes quality assurance, regulatory adherence, and customer-centric service. Raivansa operates a B2B-focused e-commerce platform and accepts custom orders for healthcare facilities seeking reliable, affordable medical supplies with fast domestic shipping.

Qisda Corporation is a global technology conglomerate founded in 1984, headquartered in Taiwan. The company operates across five major business segments: displays, projectors, medical devices, smart solutions, and networking services. In the medical sector, Qisda has developed a diversified medical fleet (醫療艦隊) encompassing six key domains: medical equipment, medical consumables, hemodialysis, medical imaging, health & wellness devices, and medical services. The company owns two large integrated hospitals and operates as both a medical device manufacturer and healthcare distribution provider. Qisda is recognized as a Thomson Reuters Global Tech 100 leader, an Asia Best Employer, and a Taiwan Top 10 Sustainability Enterprise. In displays, Qisda ranks as the world's second-largest LCD panel manufacturer, serving consumer, commercial, professional, and medical applications. In projectors, the company ranks in the global top three, holding the second-largest market share in DLP projection technology. The medical business serves first-line healthcare users with integrated solutions across hospital infrastructure, clinical diagnostics, renal therapy, imaging systems, consumer health products, and healthcare management services. Smart solutions span six verticals: smart retail, smart healthcare, smart energy, smart manufacturing, smart enterprise, and smart education, emphasizing hardware-software integration and one-stop provisioning. The networking division provides comprehensive broadband services including wired/wireless networks, broadband infrastructure, systems integration, and 5G enterprise private networks. Qisda operates manufacturing facilities and sales offices across 60+ countries with approximately 30,000 employees.

Footprint Medical Incorporated is a neonatal-focused medical device company specializing in peripherally inserted central catheter (PICC) insertion products and related neonatal interventional supplies. Based in San Antonio, Texas, the company manufactures and distributes products designed for critically ill neonates and infants in intensive care settings. Their product portfolio includes PICC insertion trays and accessories, umbilical catheters, urinary drainage systems, and enteral feeding solutions—all designed specifically for the unique anatomical and clinical requirements of premature and vulnerable newborns. The company markets its offerings as purpose-built neonatal solutions supporting vascular access, fluid management, and nutritional support in NICU environments. Footprint Medical operates a direct-to-hospital model supplemented by specialty distributor partnerships, allowing regional flexibility in market reach. The company emphasizes clinical training and education, offering PICC insertion training programs to nursing and clinical staff. Business operations center on a 5-day work week in San Antonio, with established distribution and customer support infrastructure. While specific regulatory credentials are not detailed on the accessible site pages, neonatal medical devices of this nature typically require FDA 510(k) clearance or equivalent regulatory approval. The company targets neonatal intensive care units and regional perinatal centers where specialized vascular access and feeding support are critical clinical requirements.

ALN S.A.R.L. is a French manufacturer of medical devices specializing in inferior vena cava (IVC) filters and associated retrieval/repositioning kits for pulmonary embolism prevention. Founded over 30 years ago, the company operates manufacturing facilities in Bormes-les-Mimosas (Var, Provence-Alpes-Côte d'Azur) and Thyez (Haute-Savoie, Auvergne-Rhône-Alpes), leveraging regional expertise in precision medical device technology. ALN's core product portfolio includes optional permanent and temporary IVC filters (with and without hooks), the newer ALN OATF IVC filter generation, and three specialized kits for filter extraction and repositioning. The company distributes products both through direct sales force and an established network of trained distributors across France and internationally. ALN maintains ISO quality management systems and CE marking compliance for all devices. The company has published clinical evidence, including successful retrieval data on 29 ALN IVC filters at mean 25.6-month follow-up. Products are designed for interventional radiologists and vascular specialists managing venous thromboembolism patients. All devices comply with European Medical Device Regulation; availability varies by country per local regulatory and medical practice requirements. The company emphasizes continuous innovation, rigorous quality control, and clinician training as core operational pillars.

NIPRO Technical Solutions is a dialysis equipment service and parts provider serving the U.S. hemodialysis market for over 25 years. The company operates as a depot repair center for hemodialysis machines, offering quick turnaround repairs with a 6-month warranty. Core service lines include hemodialysis parts inventory and logistics (compatible with 2008K, 2008K2, 2008T, 2008T BlueStar, and SURDIAL™ DX systems), calibration and quality assurance for dialysate meters and reference solutions, and field service engineering for maintenance and repairs on major U.S. hemodialysis brands. NIPRO also manufactures and sells biomedical technician assist devices, including the Genius 614 Valve & Chamber Analyzer (automated balance chamber testing), BTA-612 Selectable Voltage Power Supply, motor shields, and valve repair kits. The company provides technical support via phone and email, with skilled technicians answering troubleshooting inquiries. Additionally, NIPRO operates a manufacturing service center offering customizable production capabilities for medical device clients globally and maintains ISO-certified quality systems developed over 25+ years. The SURDIAL™ DX Hemodialysis System is their proprietary hemodialysis device, marketed for clinical performance, patient comfort, and operational efficiency. Target customers include hospital dialysis centers, independent dialysis providers, biomedical technician departments, and medical device manufacturers.

Edlaw Pharmaceuticals, Inc. is an FDA and NY State-registered medical device manufacturer specializing in small-batch production and packaging of dry pharmaceutical ingredients for dialysis and clinical applications. Based in Farmingdale, NY, with over 40 years of industry experience, the company manufactures products under USP standards and strict cGMP compliance. Core offerings include dialysate additives (potassium, calcium, and magnesium chloride formulations) designed to adjust dialysate bath composition to individual patient physiological requirements, and citric acid cleaning solutions for dialysis equipment maintenance. Edlaw provides comprehensive contract packaging services with precision fill capabilities (1–5000 grams, tolerances to ±0.05 grams), batch/lot coding, barcode integration, custom labeling, and climate-controlled warehouse storage. The company serves hospitals, dialysis centers, and pharmaceutical manufacturers requiring reliable, compliant small-to-medium production runs and specialty formulations.

Health Line International Corporation is a US manufacturer of vascular access catheters, infusion therapy devices, and related consumables. The company specializes in power-injectable, multi-lumen intravenous catheter kits for adult, pediatric, and neonatal patients. Product lines include PICC line kits (single, double, triple lumen configurations), midline catheter kits, central venous catheter (CVC) kits, hemodialysis catheter kits (tunneled and non-tunneled for temporary, chronic, and permanent dialysis), and IV administration sets (DEHP-free primary, secondary, and extension sets with gravity and pump compatibility). Branded products include SYNERGY CT PICC Line Kits, Health Line CT Midline Catheter Kits, and ORION Central Venous Catheter Kits. The company operates as both a direct manufacturer and OEM supplier to global distribution partners. Health Line emphasizes lean manufacturing, cost-effectiveness, product durability, and patient comfort in catheter design. The company maintains a distributor network model and targets hospital and clinical infusion therapy markets. No specific FDA 510(k), ISO, or CE certifications are mentioned on the fetched content.

Integer Holdings Corporation (NYSE: ITGR) is a global leader in medical device contract development and manufacturing (CDMO), with 80+ years of expertise in advanced medical device design, outsourcing, and component manufacturing. The company specializes in cardiac rhythm management, neuromodulation, vascular access, and cardiovascular devices. Integer operates through subsidiary brands Greatbatch Medical and Lake Region Medical, serving major global OEM medical device manufacturers across multiple therapeutic markets. The company designs and manufactures finished device systems and Class III medical devices, including catheters, guidewires, introducers, delivery systems, tantalum capacitors, implantable and external batteries, pacemaker batteries, implantable ports, and neuromodulation devices. Integer operates a vertically integrated supply chain with global R&D and manufacturing capabilities across four continents, supporting rapid prototyping, product development, testing and regulatory certification, product lifecycle management, and on-time delivery. The company serves 15+ medical device markets including cardiac rhythm management, neuromodulation, vascular access, cardiovascular, structural heart, electrophysiology, peripheral vascular, neurovascular, oncology, urology, infusion therapy, and hemodialysis. Integer is a manufacturing excellence organization with deep expertise in regulatory compliance, quality standards, and design optimization to minimize risk and accelerate time-to-market for OEM partners.

MP Seating Inc. is a medical furniture manufacturer specializing in dialysis and treatment chairs. The company designs and manufactures the Leapfrog Medical Recliner, a patient treatment chair engineered for both clinical efficacy and operational efficiency in dialysis and renal care settings. Key design features include hands-free Trendelenburg positioning for patient safety, tool-free removable seat cushions to facilitate cleaning and infection control, ultra-soft non-PVC upholstery, and dual-density foam seating for patient comfort. The chair incorporates modular, repair-friendly components to reduce total cost of ownership and streamline in-clinic maintenance. MP Seating emphasizes infection control and disinfection ease—critical requirements in dialysis centers—alongside environmental stewardship through material selection. The company operates from Elkhart, Indiana, serving healthcare providers in the nephrology and dialysis market. Products are designed with attention to both patient care outcomes and nursing workflow efficiency, addressing both the clinical and operational needs of treatment facilities.

Laminate Medical Technologies develops specialized medical devices for arteriovenous fistula (AVF) management in hemodialysis patients. The company's flagship product is the VasQ™ Extravascular Support, designed to improve AVF function and durability. VasQ™ received FDA Transitional Pass-Through (TPT) Payment designation as of October 2024, indicating recognition as a breakthrough technology offering clinically meaningful advantages for patients requiring renal replacement therapy. The device addresses a significant clinical need in the dialysis population, where AVF maturation failure and stenosis remain common complications. Laminate operates with a global focus on improving outcomes for hemodialysis-dependent patients worldwide.

Amsino International, Inc. is a manufacturer and distributor of single-use medical consumables and disposable medical devices serving hospitals, long-term care facilities, and healthcare providers. The company's primary product portfolio includes prefilled syringes, sterile water and saline solutions, and comprehensive proprietary product lines under the AMSafe®, AMSure®, and MedXL brands. The AMSafe® line encompasses IV infusion and medication delivery systems including MicroClave® products. The AMSure® portfolio covers enteral feeding systems (syringes, feeding sets, feeding pumps, irrigation trays), respiratory therapy systems, urological care products designed to reduce urinary tract infections, and surgical/nursing ancillary products. The company also manufactures RECEPTAL® suction and fluid management systems for hospital waste management. Amsino operates contract manufacturing services for both proprietary and client-developed products. The company is positioned as a physician-preferred supplier serving U.S. healthcare facilities through direct sales and order management. Product offerings are designed for clinical environments including ICU, long-term care, and acute care settings. The company maintains multilingual support (English, Spanish, Chinese) and provides comprehensive customer service including returns, quality assurance, and technical support.

Health Data Works develops Veristra™, an FDA Breakthrough Device software platform for dialysis access tracking and optimization. The platform provides real-time logging and visual mapping of dialysis access cannulation sites, enabling precision tracking with dynamic image records, symbolic overlays of current and prior puncture points, and heatmap visualizations to highlight high-use zones and emerging complications. Veristra™ delivers frontline decision support to technicians for optimal cannulation site selection, reducing dialysis initiation time and lowering complication risks. The platform provides patient-centered insights with comprehensive real-time visibility for the entire care team, automated oversight and analytics tracking technician activity with actionable performance reports, and collaborative integration designed for vascular access centers and interventional clinics. The system supports compliance with CMS guidelines and value-based care goals. Health Data Works operates on a capital-efficient SaaS model and is led by experienced clinicians, technologists, and healthcare entrepreneurs. The company serves dialysis centers, vascular access specialists, and interventional clinics seeking to optimize access site management and improve patient safety outcomes.

Dravon Medical is an FDA-registered, ISO 13485:2016-certified contract manufacturer specializing in precision medical device production since 1974. Core expertise centers on Radio Frequency (RF) welding of thermoplastic medical fluid bags—including IV bags, drainage collection bags, solution bags, blood and plasma bags, and reagent bags. The company offers comprehensive design-for-manufacturing (DFM) services, flexible small-volume production runs, and materials expertise including non-DEHP and PVC-free options. Dravon also manufactures and distributes proprietary disposable medical clamps: A-Clamps for occluding medical tubing (widely used in blood collection and dialysis centers) and T-Clamps for securing surgical drapes, sponges, and towels. Production occurs in two Class 10,000 clean rooms in Clackamas, Oregon, supporting full assembly, heat sealing, sterile packaging, and quality inspection. The company serves OEMs of all sizes—from established device manufacturers to emerging startups—with responsive technical support, competitive pricing, and guaranteed regulatory compliance.

Nephros, Inc. is a medical technology company specializing in advanced water filtration and blood-purification solutions for healthcare and commercial markets. Founded in 1997 with deep expertise in dialysis water systems, Nephros manufactures FDA Class II medical-grade ultrafilters and microfilters designed to remove biological contaminants, endotoxins, and pyrogens from water. The company serves over 500 hospitals and dialysis centers with three core product lines: infection control filtration (point-of-use micro- and ultrafilters for sinks, showers, and ice machines), dialysis water filtration (supporting central systems and RO/DI equipment to meet AAMI standards), and commercial filtration (polyphosphate-free solutions for beverage, ice, and food service applications). Nephros also provides comprehensive water management support including system evaluations, emergency response, ice machine audits, risk mitigation strategies, and water safety education to healthcare facilities and commercial customers seeking to maintain compliance and prevent waterborne pathogen exposure.

NIMedical (InnovaMed Sphere Inc.) is a biotechnology company specializing in non-invasive hemodynamic monitoring solutions. The company develops and manufactures whole-body bioimpedance systems, primarily the NICaS (Non-Invasive Cardiac System) and the Hemodynamic Navigator. NICaS is a clinically validated, cost-effective system that provides accurate hemodynamic and fluid management assessment without invasive procedures. The device measures cardiac output, stroke volume, and systemic vascular resistance, enabling physicians to isolate the exact cause of hemodynamic instability. NICaS is applicable across multiple clinical settings including acute heart failure, hypertension management, preeclampsia assessment, dialysis monitoring, ICU/ICCU care, and pharmaceutical clinical trials. The system is mobile, patient-friendly, and can be operated by various medical professionals with minimal training. NIMedical's technology is backed by extensive peer-reviewed clinical validation and is positioned as a standard-of-care solution for hemodynamic management in cardiovascular disease.

Transonic Systems Inc. is a medical device manufacturer specializing in ultrasonic Transit-Time blood flow measurement technologies. Founded in 1983 and headquartered in Ithaca, New York, the company provides precision measurement solutions for surgical, clinical, research, and OEM applications. Transonic's product portfolio includes intraoperative blood flow meters for cardiothoracic, cerebrovascular, transplant, and microvascular surgery; hemodialysis flow monitors for vascular access assessment; mechanical circulatory support flow measurement systems for ECMO and cardiopulmonary bypass; tubing flowsensors for biomedical research and device manufacturing; and comprehensive life science research instrumentation for blood flow, pressure, and cardiac output measurement. The company also offers Transonic-Inside™, a customizable OEM integration program enabling medical device developers to embed advanced flow measurement capabilities into their platforms. With global operations across the US, Europe, Asia, Japan, and Taiwan, Transonic serves hospitals, research institutions, and medical device manufacturers seeking gold-standard accuracy and validation-backed measurement solutions.

Pain Care Labs (dba MMJ Labs) is a leader in noninvasive, drug-free pain relief devices founded in 2006 by Dr. Amy Baxter, a pediatric emergency physician and pain researcher. Headquartered in Atlanta, GA, the company manufactures FDA 510(k)-cleared wearable medical devices utilizing patented mechanical stimulation (M-Stim™) technology, vibration frequencies, and thermal therapies to activate the body's natural pain response system. The company's product portfolio includes Buzzy® (needle pain and fear management for vaccinations, phlebotomy, IV access, and injections, with over 37 million documented procedures); VibraCool® (focal muscle vibration therapy for acute and chronic musculoskeletal pain, post-surgical recovery, and injury management); Buzzy® Pro (adult-focused version for dialysis and blood draw procedures); VibraCool® Pro (intensive M-stim with modular heat and ice for clinical settings); and DuoTherm (patent-pending low back pain brace combining M-stim vibrations with thermal therapy). All devices are rechargeable, reusable, and FDA-cleared. Products are deployed in over 5,000 hospitals and clinics across 28 countries. Pain Care Labs emphasizes cost-effectiveness, clinical evidence (50+ independent studies), patient satisfaction, and opioid-reduction strategies. Distribution includes retail channels (CVS) and direct-to-consumer, healthcare professional, and pharmaceutical partnership models.

MAK Healthcare is a leading full-service provider of pre-owned and refurbished diagnostic imaging and medical equipment worldwide. With over 15 years of industry experience, the company specializes in selling, purchasing, and supplying high-quality medical imaging systems to private clinics, imaging centers, hospitals, and biomedical shops throughout the U.S. and globally. MAK Healthcare is known for integrity, expertise, and cost-effective procurement solutions, partnering with trusted manufacturers including Philips, GE Healthcare, Siemens, Hitachi, and Toshiba. The company serves as a procurement partner for ISO-certified facilities seeking reliable, affordable alternatives to new equipment without compromising on diagnostic quality.

N8 Medical LLC is a clinical-stage medical device company specializing in antimicrobial coating technology based on ceragenins—a novel class of active compounds that mimic innate immune system antimicrobial peptides. The company's lead product, CeraShield, is an antimicrobial coating applied to indwelling medical devices and implants to prevent hospital-acquired infections (HAIs) and biofilm formation. The flagship device is the CeraShield Endotracheal Tube (ETT), designed to prevent Ventilator-Associated Pneumonia (VAP), the most common and costly HAI in ICU settings with estimated global treatment costs exceeding $10 billion annually. The FDA has designated CeraShield ETT as a "Breakthrough Device" and it is cleared for routine clinical use in Canada, Colombia, Brazil, and the UAE, with FDA approval anticipated. N8 Medical's pipeline includes additional CeraShield-coated devices: an antimicrobial absorbable pacemaker envelope for prevention of cardiac implantable electronic device (CIED) infections, and coated pedicle screws for orthopedic implant-associated infection prevention. The company is also developing CeraShield-coated hemodialysis catheters. N8 Medical operates as part of N8 Biosciences holding company and maintains a pharmaceutical subsidiary, Kinnear Pharmaceuticals, advancing therapeutic drug development using ceragenins for cystic fibrosis and other conditions. The company has received multiple NIH SBIR grants and maintains partnerships with government agencies including USAMRIID for biodefense applications.

BIO-MED HEALTHCARE PRODUCTS PVT is an India-based medical device manufacturer and distributor specializing in consumables, diagnostic equipment, and respiratory/therapeutic devices. The company markets seven primary product lines: Infusion Therapy (IV cannulas, catheter sets, scalp vein sets), Respiratory Devices (breathing support and pulmonary function tools including lung exercisers), Diabetic Products (glucose monitoring and management supplies), Haemodialysis (dialysis consumables and accessories), Urology (urological catheters and devices), Electrocardiography (ECG systems and monitoring equipment), and Surgery (surgical instruments and supplies). The company serves hospitals, clinics, and healthcare facilities across India and international markets, with documented participation in major medical trade exhibitions including Arab Health, Medica, IPHEX, and FIME. BIO-MED positions itself as a quality-focused manufacturer emphasizing regulatory compliance and healthcare innovation. The product portfolio spans both single-use consumables and reusable medical devices, with particular strength in infusion therapy and respiratory care. The company maintains technical documentation and downloadable product catalogs, indicating B2B-oriented sales operations. No specific FDA, CE, or ISO certifications are explicitly stated on the homepage, though participation in international exhibitions suggests compliance with relevant regulatory frameworks.

Healthward Technology, INC is a US-headquartered manufacturer and distributor of comprehensive medical furniture, equipment, and healthcare solutions. The company specializes in hospital beds (electric, manual, obstetric, and orthopedic models), patient room furniture (overbed tables, bedside cabinets, mattresses), pediatric beds and bassinets, examination and consulting room equipment (examination tables, gynecological tables, dialysis chairs, blood donation chairs), patient transport solutions (in-hospital stretchers, ambulance stretchers, stair stretchers, foldable stretchers, spine boards), medical carts (ABS, stainless steel, MDF, mild steel), and operating room equipment (manual and electric operating tables, orthopedic frames). The company also offers surgical support equipment including medical lamps, ICU surgical pendants, surgical instruments, sterilizers, suction systems, and anesthesia machines. Healthward operates 400 employees across a 50,000 sq. meter production facility and maintains 20 years of export experience, serving 562 product variants. The company delivers integrated ward solutions for smart ICU, VIP, operating room, outpatient clinic, general ward, and pediatric care settings. Customer base includes public hospitals, medical stores, and healthcare facilities worldwide. Products emphasize patient safety, comfort, and operational efficiency for acute care, rehabilitation, and pre-hospital rescue environments.

Serim Research Corporation is a manufacturer of specialty diagnostic test strips founded in 1988. The company specializes in FDA-cleared rapid testing solutions for dialysis centers, hospitals, surgery centers, and food production facilities. Core product lines include GUARDIAN® test strips for dialysis water quality and disinfectant monitoring, DISINTEK™ strips for high-level disinfectant verification in endoscopy and sterile processing, PINNACLE™ strips for cleaning validation in central service departments, MONITOR™ strips for food safety and sanitization applications, and PyloriTek® rapid urease tests for H. pylori detection. The company also provides custom test strip development, contract manufacturing, and private label solutions serving multiple industries including healthcare, food production, and laundry disinfection.